Odyssean »

Celanese Corporation shares owned by Odyssean

Quarter-by-quarter ownership of Celanese Corporation (CE) shares owned by Odyssean from 13F filings

Historical chart of Odyssean investment in Celanese Corporation

Tip: Access up to 7 years of quarterly data

All positions including Celanese Corporation held by Odyssean consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celanese Corporation by Odyssean

Quarter filed Position value Share count Share price at filing
2026-06-30 $225k 4.9k 46.00

More positions owned by Odyssean

Ultragenyx Pharmaceutical (RARE)
Kymera Therapeutics (KYMR)
Ideaya Biosciences (IDYA)
Vaxcyte (PCVX)
Affirm Hldgs Com Cl A (AFRM)
Celldex Therapeutics Com New (CLDX)
Loar Holdings Com Shs (LOAR)
Mirum Pharmaceuticals (MIRM)
Doordash Cl A (DASH)
Krystal Biotech (KRYS)
Viking Holdings Ord Shs (VIK)
Medpace Hldgs (MEDP)
Toast Cl A (TOST)
American Healthcare Reit Com Shs (AHR)
Nicolet Bankshares (NIC)

View all positions for Odyssean

Top funds holding Celanese Corporation

Dodge & Cox
BlackRock
Vanguard Portfolio Management
Vanguard Capital Management
Capital Research Global Investors
State Street Corporation
Hanna Zanoni
Dimensional Fund Advisors
Capital World Investors
Turtle Creek Asset Management
Federated Investors
Ing Investment Management
Geode Capital Management
Millennium Management
Charles Schwab Investment Management

View all funds holding Celanese Corporation